Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 December 2008. doi:10.1136/ard.2008.100271
Annals of the Rheumatic Diseases 2009;68:1680-1685
Copyright © 2009 BMJ Publishing Group Ltd & European League Against Rheumatism.

CLINICAL AND EPIDEMIOLOGICAL RESEARCH

Extended report

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative

L Gossec1,2, M Dougados1, N Rincheval2, A Balanescu3, D T Boumpas4, S Canadelo5, L Carmona6, J-P Daurès2, M de Wit5, B A C Dijkmans7, M Englbrecht8, Z Gunendi9, T Heiberg10, J R Kirwan11, E M Mola12, M Matucci-Cerinic13, K Otsa14, G Schett8, T Sokka15, G A Wells16, G J Aanerud10, A Celano13, A Dudkin14, C Hernandez12, K Koutsogianni4, F N Akca9, A-M Petre3, P Richards11, M Scholte-Voshaar7, G Von Krause1, T K Kvien17,18

1 Paris Descartes University, Medicine Faculty, UPRES-EA 4058, APHP, Rheumatology B Department, Cochin Hospital, Paris France
2 Epidemiology and Statistics Department, Montpellier Medicine Faculty, Montpellier, France
3 Research Center of Rheumatic Diseases, "Sf Maria" Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania
4 Rheumatology, Clinical Immunology and Allergy, University of Crete, Faculty of Medicine, Heraklion, Greece
5 EULAR standing committee of People with Arthritis/Rheumatism in Europe (PARE), Zurich, Switzerland
6 Research Unit, Spanish Foundation of Rheumatology, Madrid, Spain
7 Rheumatology, VU University Medical Center and Jan van Breemen Institute, The Netherlands
8 Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany
9 University of Gazi, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Ankara, Turkey
10 Department for Research and Education, Ulleval University Hospital, Oslo, Norway
11 University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK
12 Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain
13 Department of Medicine, Division of Rheumatology AOUC, Denothe Centre, University of Florence, Firenze, Italy
14 Rheumatology Department, Tallinn Central Hospital, Estonia
15 Jyväskylä Central Hospital, Jyväskylä, Finland
16 University of Ottawa Heart Institute, Ottawa, Ontario, Canada
17 Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
18 Faculty of Medicine, University of Oslo, Oslo, Norway

Correspondence to Dr L Gossec, Service de Rhumatologie B, Hôpital Cochin, 27, rue du faubourg Saint-Jacques, 75014 Paris, France; laure.gossec{at}cch.aphp.fr

Background: Current response criteria in rheumatoid arthritis (RA) usually assess only three patient-reported outcomes (PROs): pain, functional disability and patient global assessment. Other important PROs such as fatigue are not included.

Objective: To elaborate a patient-derived composite response index for use in clinical trials in RA, the RA Impact of Disease (RAID) score.

Methods: Ten patients identified 17 domains or areas of health relevant for inclusion in the score, then 96 patients (10 per country in 10 European countries) ranked these domains in order of decreasing importance. The seven most important domains were selected. Instruments were chosen for each domain after extensive literature research of psychometric properties and expert opinion. The relative weight of each of the domains was obtained from 505 patients who were asked to "distribute 100 points" among the seven domains. The average ranks of importance of these domains were then computed.

Results: The RAID score includes seven domains with the following relative weights: pain (21%), functional disability (16%), fatigue (15%), emotional well-being (12%), sleep (12%), coping (12%) and physical well-being (12%). Weights were similar across countries and across patient and disease characteristics. Proposed instruments include the Health Assessment Questionnaire and numerical ratings scales.

Conclusion: The preliminary RAID score is a patient-derived weighted score to assess the impact of RA. An ongoing study will allow the final choice of questionnaires and assessment of validity. This score can be used in clinical trials as a new composite index that captures information relevant to patients.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs